XXD-63965-01405
2 vaccinations
12 coded responses
20 check-ins
12 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 973 / OR
- Registered
- 2021-07-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-07-15
Dose 1 — Pfizer-BioNTech
-
2021-07-17
Registered in v-safe
-
2021-07-17
Survey response — days 1–6 daily, dose 1MedDRA: Skin burning sensation — Feeling: Poor · Site: Redness, Swelling, Itching · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2021-07-18
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Poor · Site: Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2021-07-20
Survey response — days 1–6 daily, dose 1MedDRA: Neuralgia — Feeling: Poor · Site: Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11 · check-in answers available
-
2021-07-20
Report sent to call center — days 1–6 daily, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-07-21
Survey response — days 1–6 daily, dose 1MedDRA: Neuralgia, Pre-existing disease — Feeling: Poor · Site: Redness, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2021-07-22
Survey response — 7 day, dose 1MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2021-07-27
- 2021-07-29
- 2021-07-30
-
2021-08-05
Dose 2 — Pfizer-BioNTech
- 2021-08-05
-
2021-08-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-08-07
Survey response — days 1–6 daily, dose 2MedDRA: Breast pain, Chest pain — Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2024-11 · check-in answers available
-
2021-08-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-08-09
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: Poor · Fever · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2024-11 · check-in answers available
-
2021-08-12
Health check-in — 7 day, dose 2Feeling: Poor · Fever · Headache, Joint pains, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-08-19
Survey response — 14 day, dose 2MedDRA: Chest discomfort, Chest pain, Cough, Oxygen saturation decreased, Respiratory tract congestion, SARS-CoV-2 test — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2021-09,2024-11 · check-in answers available
-
2021-08-19
Report sent to call center — 14 day, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-08-26
Survey response — 21 day, dose 2MedDRA: Candida infection, Rash — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2021-09,2024-11 · check-in answers available
-
2021-08-26
Report sent to call center — 21 day, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-08-26
Call successfulCompleted over the phone
- 2021-09-02
-
2021-09-11
Survey response — 35 day, dose 2MedDRA: Arthralgia, Chest pain, Oral candidiasis, Rash, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11 · check-in answers available
-
2021-09-11
Report sent to call center — 35 day, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-09-13
Call successfulCompleted over the phone
- 2021-09-18
- 2021-11-04
-
2022-02-05
Survey response — 6 month, dose 2MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11 · check-in answers available
-
2022-02-05
Report sent to call center — 6 month, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-02-07
- 2022-02-10
-
2022-08-06
Survey response — 12 month, dose 2MedDRA: Arthralgia, Herpes zoster, Mobility decreased, Pain in extremity, Sciatica — Feeling: Poor · Be unable to work or attend schoolMedDRA releases: 2024-11 · check-in answers available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-15 | Pfizer-BioNTech | No |
| 2 | 2021-08-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-20 | Successful | Completed over the phone |
| 2021-08-19 | Successful 2021-08-26 |
Completed over the phone |
| 2021-08-26 | Successful 2021-09-13 |
Completed over the phone |
| 2021-09-11 | Successful | Completed over the phone |
| 2022-02-05 | Unsuccessful |
Free text
Release 9
Systemic reaction (other): My face felt like it was on fire, all symptoms started last night
Systemic reaction (other): Im a long hauler and I think the vaccine has triggered a relapse in my situation
Systemic reaction (other): Nerve pain in my legs
Systemic reaction (other): Im in a long Covid relapse off symptoms. Im also experiencing new nerve pain not experienced prior but Im managing.
Systemic reaction (other): Vaccine is triggered a relapse of Long Covid symptoms
Systemic reaction (other): Chest pain and pain side of breast area
Systemic reaction (other): Sore throat
Symptoms: Chest pain/tightness, low O2 levels Congestion coughWas tested for Covid
Symptoms: Thrush and rash on torso and back
Symptoms: Increased joint pain, chest pain right side, remnants of thrush in mouth, may need another round of antibiotics. Still have the marks on my body from the rash.
Healthcare visit (other): Next appointment on Monday 9/13
Release 11
Symptoms: Covid positive on 1/6
Release 12
Symptoms: Shingles, followed by intense sciatic pain in lower back, hip pain and right leg pain limiting my mobility going on week 10
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Candida infection | ✓ | · | ✓ |
| SD | Chest discomfort | ✓ | · | ✓ |
| SD | Chest pain | ✓ | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Herpes zoster | · | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Oral candidiasis | · | · | ✓ |
| SD | Oxygen saturation decreased | ✓ | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Rash | ✓ | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SD | SARS-CoV-2 test | ✓ | · | ✓ |
| SD | Sciatica | · | · | ✓ |
| SRO | Breast pain | ✓ | · | ✓ |
| SRO | Chest pain | ✓ | · | ✓ |
| SRO | Condition aggravated | · | · | ✓ |
| SRO | Neuralgia | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Skin burning sensation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release